Restrictive Versus Liberal Transfusion in Patients With Type 1 or Type 2 Myocardial Infarction: A Prespecified Analysis of the MINT Trial
Maria M. Brooks, Paul C. Hébert, Caroline Alsweiler, Andrew P. DeFilippis et al.
Citations
18 citations
Journal
Circulation
Topics
Acute Myocardial Infarction Research
Field-Weighted Citation Impact (FWCI)
7.24
article
Restrictive Versus Liberal Transfusion in Patients With Type 1 or Type 2 Myocardial Infarction: A Prespecified Analysis of the MINT Trial
Maria M. Brooks, Paul C. Hébert, Caroline Alsweiler, Andrew P. DeFilippis, Jeffrey L. Carson, Sunil V. Rao, Rajesh Gupta, Benoit Daneault, Mark Menegus, Johanne Silvain, Marnie Bertolet, Andrew M. Goldsweig, Shaun G. Goodman, Harvey D. White, Renato D. Lópes, Brandon M. Herbert, John Hunter Alexander, Tamar S. Polonsky, Bernard Chaitman, J. Dawn Abbott, Pedro Gabriel Melo de Barros e Silva, Meechai Tessalee, Graham S. Hillis
article en
18 citations
Abstract
No abstract available for this paper.
Publication Tag
CirculationVol. 150(23)
Institutions
St. Michael's Hospital (CA), University Health Network (CA), Montefiore Medical Center (US), Baystate Medical Center (US), Inserm (FR), University of Pittsburgh (US), The University of Western Australia (AU), University of Missouri–St. Louis (US), Brown University (US), Royal Perth Hospital (AU), Centre Hospitalier Universitaire de Sherbrooke (CA), Johnson University (US), Sorbonne Université (FR), University of Chicago (US), NYU Langone Health (US), Clinical Research Institute (US), Greenlane Clinical Centre (NZ), Assistance Publique – Hôpitaux de Paris (FR), Canadian VIGOUR Centre (CA), Pitié-Salpêtrière Hospital (FR), Bruyère (CA), Saint Louis University (US), Vanderbilt University Medical Center (US), University of Toledo (US)
Funders
Amgen, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, AstraZeneca, GlaxoSmithKline, Sanofi, Cleveland Clinic, AtriCure, CSL Behring, Regeneron Pharmaceuticals, CryoLife, Canadian Blood Services, Agence Nationale de la Recherche, Daiichi-Sankyo, Novo Nordisk, Servier, Idorsia Pharmaceuticals, HLS Therapeutics, Sanofi Australia, Esperion Therapeutics, National Institutes of Health, U.S. Food and Drug Administration, Genentech, American Regent, Canadian Institutes of Health Research, National Heart, Lung, and Blood Institute, Institute of Circulatory and Respiratory Health, Daiichi Sankyo Europe